Amiodarone and Lung Toxicity in Hamsters
Author Information
Author(s): S. N. Giri, D. M. Hyde, D. R. Haynam, M. Casias
Primary Institution: School of Veterinary Medicine, University of California, Davis, CA, USA
Hypothesis
The study tests the effectiveness of the PAF antagonist WEB 2086 against amiodarone-induced lung fibrosis and phospholipidosis.
Conclusion
The PAF receptor antagonist WEB 2086 significantly reduced lung toxicity caused by amiodarone in hamsters.
Supporting Evidence
- WEB 2086 minimized the increases in lung hydroxyproline and phospholipid content caused by amiodarone.
- Treatment with WEB 2086 reduced acute mortality from 35% to 22% in hamsters treated with amiodarone.
- Histopathological studies showed reduced lung lesions in the WEB + AMD group compared to the saline + AMD group.
Takeaway
Amiodarone can harm the lungs, but a special medicine called WEB 2086 can help protect them.
Methodology
Hamsters were divided into four groups and treated with saline or WEB 2086 before receiving amiodarone or water, followed by various assays after 28 days.
Limitations
The findings in hamsters may not directly translate to humans due to differences in drug administration and fibrosis development.
Participant Demographics
Male Golden Syrian hamsters weighing 112-128 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website